We have previously demonstrated that the induction of Thymic Stromal Lymphopoietin (TSLP) leads to a robust antitumor CD4+ T helper 2 (Th2) cell immunity that suppresses skin and breast cancer development [9,10]. Here, CD4 is linked to breast carcinoma.